OR Royalties Inc. (NYSE:OR) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of OR Royalties Inc. (NYSE:OR) have been assigned a consensus recommendation of “Moderate Buy” from the nine analysts that are presently covering the firm, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation, four have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $46.50.

OR has been the topic of a number of research reports. Zacks Research lowered shares of OR Royalties from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, March 31st. Weiss Ratings lowered shares of OR Royalties from a “buy (b)” rating to a “buy (b-)” rating in a research report on Thursday, June 4th. Royal Bank Of Canada reiterated an “outperform” rating and set a $56.00 price objective on shares of OR Royalties in a research note on Friday, April 10th. Finally, Wall Street Zen downgraded shares of OR Royalties from a “buy” rating to a “hold” rating in a research note on Saturday, June 6th.

OR Royalties Stock Performance

Shares of NYSE:OR opened at $31.60 on Wednesday. The firm has a market cap of $5.92 billion, a PE ratio of 23.58 and a beta of 0.70. The firm’s 50 day simple moving average is $36.08 and its 200-day simple moving average is $38.69. OR Royalties has a one year low of $25.14 and a one year high of $48.06.

OR Royalties (NYSE:OR) last issued its earnings results on Wednesday, May 6th. The basic materials company reported $0.40 EPS for the quarter, topping analysts’ consensus estimates of $0.34 by $0.06. The business had revenue of $102.83 million for the quarter, compared to analyst estimates of $103.27 million. OR Royalties had a net margin of 78.09% and a return on equity of 15.10%. Equities research analysts predict that OR Royalties will post 1.4 EPS for the current fiscal year.

OR Royalties Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Tuesday, June 30th will be paid a dividend of $0.065 per share. This is a boost from OR Royalties’s previous quarterly dividend of $0.06. This represents a $0.26 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Tuesday, June 30th. OR Royalties’s payout ratio is 16.42%.

Hedge Funds Weigh In On OR Royalties

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Groupe la Francaise boosted its stake in shares of OR Royalties by 122.2% during the first quarter. Groupe la Francaise now owns 200,000 shares of the basic materials company’s stock valued at $7,591,000 after purchasing an additional 110,000 shares in the last quarter. Bank of America Corp DE boosted its stake in shares of OR Royalties by 37.4% during the first quarter. Bank of America Corp DE now owns 1,008,086 shares of the basic materials company’s stock valued at $38,327,000 after purchasing an additional 274,486 shares in the last quarter. Janus Henderson Group PLC boosted its stake in shares of OR Royalties by 63.0% during the first quarter. Janus Henderson Group PLC now owns 29,276 shares of the basic materials company’s stock valued at $1,130,000 after purchasing an additional 11,311 shares in the last quarter. Amundi boosted its stake in OR Royalties by 8.4% in the first quarter. Amundi now owns 1,151,071 shares of the basic materials company’s stock valued at $43,764,000 after acquiring an additional 89,202 shares in the last quarter. Finally, Parvin Asset Management LLC boosted its stake in OR Royalties by 2.2% in the first quarter. Parvin Asset Management LLC now owns 70,250 shares of the basic materials company’s stock valued at $2,671,000 after acquiring an additional 1,500 shares in the last quarter. 68.52% of the stock is currently owned by institutional investors.

OR Royalties Company Profile

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.